A

Alnylam Pharmaceuticals

Develops RNAi-based therapies for genetic diseases

Scientist – Biocatalysis & Protein Engineering

Translational Research & Bench BiologyConfirmed live in the last 24 hours
Full-timeCambridge, MA, USA$117k - $158.2k

About the Job

Requirements

  • A Ph.D. in Biochemistry, Molecular Biology, Protein Engineering, Chemical Engineering, Biochemical Engineering, Chemistry, or a related discipline; an M.S. with at least 4 years of relevant industry experience; or a B.S. with at least 8 years of relevant industry experience.
  • Demonstrated experience in protein or enzyme engineering, directed evolution, or enzyme discovery.
  • Hands-on expertise in molecular biology techniques, including cloning, mutagenesis, DNA assembly, and recombinant protein expression.
  • Experience developing and executing high-throughput screening assays and analyzing large experimental datasets.
  • Strong knowledge of enzyme kinetics, structure-function relationships, and protein characterization techniques.
  • Familiarity with biocatalysis applications in small-molecule, oligonucleotide, or pharmaceutical process development.
  • Strong skills in data analysis, problem-solving, and experimental design.
  • Excellent written and verbal communication skills and the ability to collaborate effectively across functions.
  • Demonstrated ability to thrive in a fast-paced, collaborative, and innovation-driven research environment.

Responsibilities

  • Design and execute enzyme discovery and protein engineering campaigns using directed evolution, rational design, and library generation strategies to improve enzyme performance.
  • Develop and implement high-throughput screening and selection assays to assess enzyme activity, stability, substrate scope, and reaction performance.
  • Design, construct, and characterize enzyme variant libraries using molecular biology, recombinant protein expression, and protein purification techniques.
  • Develop automated workflows and use liquid-handling platforms to enable efficient screening of large enzyme libraries.
  • Characterize engineered enzymes using biochemical, biophysical, and analytical methods to guide candidate selection and process development.
  • Collaborate with computational biology, analytical sciences, process development, and external CRO and CMO partners to accelerate biocatalyst optimization.
  • Support the transfer of engineered enzymes into scalable manufacturing processes and contribute to process characterization activities.
  • Author and review experimental protocols, technical reports, and development documentation supporting research, process development, and manufacturing activities.

Desired Qualifications

  • Experience with laboratory automation, liquid-handling platforms, or high-throughput experimentation is highly desirable.

About the Company

Alnylam Pharmaceuticals

Develops RNAi-based therapies for genetic diseases

Alnylam Pharmaceuticals develops RNA interference (RNAi) therapeutics to silence disease-causing genes, aiming to treat rare genetic disorders. Its products work by using RNA molecules that block gene expression, reducing the impact of specific genetic diseases. The company differentiates itself by concentrating on RNAi-based drugs for rare diseases and by building a pipeline through large clinical programs and strategic partnerships, such as commercialization deals in the Gulf States and collaborations with investors. Revenue comes from approved drug sales, licensing agreements, strategic collaborations, and related services like genetic testing and counseling. The company’s goal is to advance and commercialize RNAi therapies to improve outcomes for patients with genetic disorders, expanding its portfolio through partnerships and investments.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Cambridge, MA
Founded
2002

Recently Posted Jobs

Explore more opportunities at Alnylam Pharmaceuticals

See more jobs